Neurological disorders are sicknesses of the brain, spine and the nerves that connect them. These disorders include Epilepsy, Alzheimer disease and other Dementias, Cerebrovascular diseases including stroke, Parkinson's disease, migraine and other headache disorders, brain tumors, multiple sclerosis, neuroinfections, traumatic disorders of the nervous system due to head trauma, and neurological disorders as a result of malnutrition.
The global stroke management market was valued at $19.2 billion in 2013 and nearly $20.2 billion in 2014. This market is expected to reach nearly $28.3 billion by 2019, with a compound annual growth rate (CAGR) of 7% from 2014 to 2019. Epilepsy is a chronic brain disorder. More than 50 million people were affected worldwide. Synchronous brain cell activity causes seizures and depending on the region of brain affected they will produce a range of behaviors. Annually NIH spends $30 billion for medical research, but ½ of 1% is only spent on epilepsy research. Dementia, including Alzheimer’s disease, is one of the biggest global public health challenges facing our generation. Worldwide, at least 44 million people are living with dementia this number is expected to double by 2030 and more than triple by 2050 to 115 million. Much of the increase will be in developing countries like Western Europe and North America. Already 62% of people with dementia live in developing countries. Parkinson’s disease is a dynamic neurological disorder that influences how the individual moves, including how they talk and compose. This disease is caused by low dopamine levels. Various useful treatments, utilizing therapies (physiotherapy), surgery and medications have recognized neurological disorders and changes in the patient group.